Amarin Corp Plc (AMRN)

[retinadoc]

Some important points to remember about Teva:
1) They alone have a CV indication for GV in the US (skinny label not in play)
2) They are capable of competing with Hikma, Reddy, and Apotex
3) They have the resources to engage in a prolonged legal battle with the above and sue insurance companies that have prior authorization CV infringement (Health net litigation)
4) The have significant presence in the EU and know the environment and regulators.
5) They were reasonable in dealing with Amarin historically.

An Amarin/Teva alliance or even acquisition has benefits for both companies